Cyclacel Pharma (CYCC) Tops Q1 EPS by 20c
Tweet
Share
E-mailGet Alerts CYCC Hot Sheet
Price: $6.37 --0%
Financial Fact:
Research and development: 2.41M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Financial Fact:
Research and development: 2.41M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Cyclacel Pharma (NASDAQ: CYCC) reported Q1 EPS of ($0.47), $0.20 better than the analyst estimate of ($0.67).
For earnings history and earnings-related data on Cyclacel Pharma (CYCC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Ridgepost Capital acquires Stellus Capital Management for $4B AUM
- NVE Corporation names new CEO and expands board to seven members
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
